Skip to main content

West Pharmaceutical Services FR revenue

  • WST · NYSE
  • Medical devices
  • Health Care Supplies
  • S&P 500
$416.42+1.24%Close 13 Nov 2026

FR revenue at West Pharmaceutical Services came to $226.6M for the fiscal year to 31 Dec 2025, down 6.4% from a year earlier.

As West Pharmaceutical Services reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 17 Feb 2026.

By fiscal year

$142.6MDec 2017$145.0MDec 2018$150.6MDec 2019$172.7MDec 2020$213.0MDec 2021$237.9MDec 2022$282.9MDec 2023$242.2MDec 2024$226.6MDec 2025
West Pharmaceutical Services FR revenue, every reported period
Period endingFR revenueChange on a yearFiled
31 Dec 2025$226.6Mdown 6.4%17 Feb 2026
31 Dec 2024$242.2Mdown 14.4%18 Feb 2025
31 Dec 2023$282.9Mup 18.9%20 Feb 2024
31 Dec 2022$237.9Mup 11.7%21 Feb 2023
31 Dec 2021$213.0Mup 23.3%22 Feb 2022
31 Dec 2020$172.7Mup 14.7%23 Feb 2021
31 Dec 2019$150.6Mup 3.9%24 Feb 2020
31 Dec 2018$145.0Mup 1.7%28 Feb 2019
31 Dec 2017$142.6M—26 Feb 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of West Pharmaceutical Services: Proprietary Products revenue · West Vantage revenue · United States revenue · Germany revenue · Ireland revenue · financial statements

Every KPI and segment of WST, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.